News en

Sensidose recruits Deputy CEO for the expansion

Pharma company Sensidose has recruited Philip Slätis as Chief Operating Officer and Deputy CEO. Slätis takes on on his role on November 1 and brings broad experience from the pharmaceutical industry. He is expected to contribute to the company’s business development...

Biostock: Continued positive sales development for Sensidose

Sensidose recently reported an increase in net sales of 21 per cent for the second quarter compared to the same period in 2021. At the same time as the company is growing, they have also made progress during the quarter in the development of the new dosing device,...

Sensidose attended SALSS 2018 – All about Brains

Sensidose participated in the Swedish-American Life Science Summit (SALSS) between the 22nd to 24th of August 2018 in Stockholm, Sweden. The summit is a by-invitation-only conference bringing together some of the most renowned Life Science executives, scientists,...

Sensidose AGM may 29 2018

The Annual General Meeting was held on May 29 at the company's premises in Sollentuna. The chairman of the meeting was elected lawyer Mikael Smedeby from Lindahl's law firm. At the annual meeting, Gunnar Säll, after 5 years as the chairman resigned. Proposed new...